Cutting edge: Interleukin 17 signals through a heteromeric receptor complex

被引:450
作者
Toy, Dean
Kugler, David
Wolfson, Martin
Vanden Bos, Tim
Gurgel, Jesse
Derry, Jonathan
Tocker, Joel
Peschon, Jacques
机构
[1] Amgen Inc, Dept Inflammat, Seattle, WA 98119 USA
[2] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA
[3] Amgen Inc, Dept Oncol, Seattle, WA 98119 USA
[4] Amgen Inc, Dept Mol Sci, Seattle, WA 98119 USA
关键词
D O I
10.4049/jimmunol.177.1.36
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-17 is an inflammatory cytokine produced primarily by a unique lineage of CD4 T cells that plays critical roles in the pathogenesis of multiple autoimmune diseases. IL-17RA is a ubiquitously expressed receptor that is essential for IL-17 biologic activity. Despite widespread receptor expression, the activity of IL-17 is most classically defined by its ability to induce the expression of inflammatory cytokines, chemokines, and other mediators by stromal cells. The lack of IL-17 responsiveness in mouse stromal cells genetically deficient in IL-17RA is poorly complemented by human IL-17RA, suggesting the presence of an obligate ancillary component whose activity is species specific. This component is IL-17RC, a distinct member of the IL-17R family. Thus, the biologic activity of IL-17 is dependent on a complex composed of IL-17RA and IL-17RC, suggesting a new paradigm for understanding the interactions between the expanded family of IL-17 ligands and their receptors.
引用
收藏
页码:36 / 39
页数:4
相关论文
共 30 条
[1]   Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[2]   p75NTR is positively promiscuous: Novel partners and new insights [J].
Barker, PA .
NEURON, 2004, 42 (04) :529-533
[3]   Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J].
Harrington, LE ;
Hatton, RD ;
Mangan, PR ;
Turner, H ;
Murphy, TL ;
Murphy, KM ;
Weaver, CT .
NATURE IMMUNOLOGY, 2005, 6 (11) :1123-1132
[4]   Soluble and transmembrane Isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer [J].
Haudenschild, D ;
Moseley, T ;
Rose, L ;
Reddi, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (06) :4309-4316
[5]   IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways [J].
Hwang, SY ;
Kim, JY ;
Kim, KW ;
Park, MK ;
Moon, Y ;
Kim, WU ;
Kim, HY .
ARTHRITIS RESEARCH & THERAPY, 2004, 6 (02) :R120-R128
[6]   IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding [J].
Hymowitz, SG ;
Filvaroff, EH ;
Yin, JP ;
Lee, J ;
Cai, LP ;
Risser, P ;
Maruoka, M ;
Mao, WG ;
Foster, J ;
Kelley, RF ;
Pan, GH ;
Gurney, AL ;
de Vos, AM ;
Starovasnik, MA .
EMBO JOURNAL, 2001, 20 (19) :5332-5341
[7]   IL-17 markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-κB signaling pathways [J].
Kao, CY ;
Chen, Y ;
Thai, P ;
Wachi, S ;
Huang, F ;
Kim, C ;
Harper, RW ;
Wu, R .
JOURNAL OF IMMUNOLOGY, 2004, 173 (05) :3482-3491
[8]   Identification of a novel cytokine, ML-1, and its expression in subjects with asthma [J].
Kawaguchi, M ;
Onuchic, LF ;
Li, XD ;
Essayan, DM ;
Schroeder, J ;
Xiao, HQ ;
Liu, MC ;
Krishnaswamy, G ;
Germino, G ;
Huang, SK .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4430-4435
[9]   Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1 [J].
Koenders, MI ;
Lubberts, E ;
Oppers-Walgreen, B ;
van den Bersselaar, L ;
Helsen, MM ;
Di Padova, FE ;
Boots, AMH ;
Gram, H ;
Joosten, LAB ;
van den Berg, WB .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (01) :141-149
[10]   Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis [J].
Koenders, MI ;
Kolls, JK ;
Oppers-Walgreen, B ;
van den Bersselaar, L ;
Joosten, LAB ;
Schurr, JR ;
Schwarzenberger, P ;
van den Berg, WB ;
Lubberts, E .
ARTHRITIS AND RHEUMATISM, 2005, 52 (10) :3239-3247